All the findings demonstrated that cisplatin-resistant gastric cancer cells communicate with sensitive cells through the delivery key exosomal protein RPS3 and the activation of PI3K-Akt-cofilin-1 signaling pathway. This evidence concerns the gene AKT1 and gastric cancer.